300 related articles for article (PubMed ID: 11990441)
1. Clinical evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans.
Sculean A; Barbé G; Chiantella GC; Arweiler NB; Berakdar M; Brecx M
J Periodontol; 2002 Apr; 73(4):401-8. PubMed ID: 11990441
[TBL] [Abstract][Full Text] [Related]
2. Four-year results of a prospective-controlled clinical study evaluating healing of intra-bony defects following treatment with an enamel matrix protein derivative alone or combined with a bioactive glass.
Sculean A; Pietruska M; Arweiler NB; Auschill TM; Nemcovsky C
J Clin Periodontol; 2007 Jun; 34(6):507-13. PubMed ID: 17451415
[TBL] [Abstract][Full Text] [Related]
3. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 5-year clinical and radiological study.
Mengel R; Schreiber D; Flores-de-Jacoby L
J Periodontol; 2006 Oct; 77(10):1781-7. PubMed ID: 17032123
[TBL] [Abstract][Full Text] [Related]
4. The effect of postsurgical antibiotics on the healing of intrabony defects following treatment with enamel matrix proteins.
Sculean A; Blaes A; Arweiler N; Reich E; Donos N; Brecx M
J Periodontol; 2001 Feb; 72(2):190-5. PubMed ID: 11288792
[TBL] [Abstract][Full Text] [Related]
5. Effects of pretreatment clinical parameters on bioactive glass implantation in intrabony periodontal defects.
Park JS; Suh JJ; Choi SH; Moon IS; Cho KS; Kim CK; Chai JK
J Periodontol; 2001 Jun; 72(6):730-40. PubMed ID: 11453234
[TBL] [Abstract][Full Text] [Related]
6. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
[TBL] [Abstract][Full Text] [Related]
7. Healing of human intrabony defects following regenerative periodontal therapy with an enamel matrix protein derivative alone or combined with a bioactive glass. A controlled clinical study.
Sculean A; Pietruska M; Schwarz F; Willershausen B; Arweiler NB; Auschill TM
J Clin Periodontol; 2005 Jan; 32(1):111-7. PubMed ID: 15642068
[TBL] [Abstract][Full Text] [Related]
8. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 12-month clinical and radiological study.
Mengel R; Soffner M; Flores-de-Jacoby L
J Periodontol; 2003 Jun; 74(6):899-908. PubMed ID: 12887004
[TBL] [Abstract][Full Text] [Related]
9. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.
Scheyer ET; Velasquez-Plata D; Brunsvold MA; Lasho DJ; Mellonig JT
J Periodontol; 2002 Apr; 73(4):423-32. PubMed ID: 11990444
[TBL] [Abstract][Full Text] [Related]
10. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study.
Froum SJ; Weinberg MA; Rosenberg E; Tarnow D
J Periodontol; 2001 Jan; 72(1):25-34. PubMed ID: 11210070
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of an enamel matrix protein derivative combined with either a natural bone mineral or beta-tricalcium phosphate.
Döri F; Arweiler N; Gera I; Sculean A
J Periodontol; 2005 Dec; 76(12):2236-43. PubMed ID: 16332235
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a bioactive glass alloplast in treating periodontal intrabony defects.
Ong MM; Eber RM; Korsnes MI; MacNeil RL; Glickman GN; Shyr Y; Wang HL
J Periodontol; 1998 Dec; 69(12):1346-54. PubMed ID: 9926764
[TBL] [Abstract][Full Text] [Related]
13. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans.
Velasquez-Plata D; Scheyer ET; Mellonig JT
J Periodontol; 2002 Apr; 73(4):433-40. PubMed ID: 11990445
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans.
Gurinsky BS; Mills MP; Mellonig JT
J Periodontol; 2004 Oct; 75(10):1309-18. PubMed ID: 15562907
[TBL] [Abstract][Full Text] [Related]
15. Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone.
Yilmaz S; Cakar G; Yildirim B; Sculean A
J Clin Periodontol; 2010 Jun; 37(6):544-50. PubMed ID: 20507378
[TBL] [Abstract][Full Text] [Related]
16. Five-year clinical and histologic results following treatment of human intrabony defects with an enamel matrix derivative combined with a natural bone mineral.
Sculean A; Chiantella GC; Arweiler NB; Becker J; Schwarz F; Stavropoulos A
Int J Periodontics Restorative Dent; 2008 Apr; 28(2):153-61. PubMed ID: 18546811
[TBL] [Abstract][Full Text] [Related]
17. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral: a pilot study.
Döri F; Kovács V; Arweiler NB; Huszár T; Gera I; Nikolidakis D; Sculean A
J Periodontol; 2009 Oct; 80(10):1599-605. PubMed ID: 19792848
[TBL] [Abstract][Full Text] [Related]
18. Effect of platelet-rich plasma on the healing of intrabony defects treated with Beta tricalcium phosphate and expanded polytetrafluoroethylene membranes.
Döri F; Huszár T; Nikolidakis D; Tihanyi D; Horváth A; Arweiler NB; Gera I; Sculean A
J Periodontol; 2008 Apr; 79(4):660-9. PubMed ID: 18380559
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial.
Siciliano VI; Andreuccetti G; Siciliano AI; Blasi A; Sculean A; Salvi GE
J Periodontol; 2011 Jan; 82(1):62-71. PubMed ID: 20809859
[TBL] [Abstract][Full Text] [Related]
20. Comparison of enamel matrix proteins and bioabsorbable membranes in the treatment of intrabony periodontal defects. A split-mouth study.
Sculean A; Donos N; Blaes A; Lauermann M; Reich E; Brecx M
J Periodontol; 1999 Mar; 70(3):255-62. PubMed ID: 10225541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
